The Trump administration has finalized a rule, effective October 13, 2026, ending federal Medicaid and CHIP funding for gender-affirming surgeries, puberty blockers, and hormone therapies for minors. CMS Administrator Dr. Mehmet Oz and HHS Secretary Robert F. Kennedy Jr. justified the ban by citing safety concerns and evidence gaps, referencing the UK's Cass Review. Major medical organizations oppose the rule, while LGBTQ+ advocates like the Human Rights Campaign have condemned the policy and promised legal challenges.
Story comments
Loading comments…